| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/21/2004 | EP1408911A1 Sustained-release therapeutic bioadhesive systems |
| 04/21/2004 | EP1408908A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 04/21/2004 | EP1408897A2 Gum resin as a carrier for topical application of pharmacologically active agents |
| 04/21/2004 | EP1408750A2 A cream-t0-powder dermatological composition |
| 04/21/2004 | EP1305049A4 Methods for treating burns on mammalian skin to reduce the risk of infection and to minimize fluid loss |
| 04/21/2004 | EP1296946B1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 04/21/2004 | EP1291011A4 Hand treatment lotion |
| 04/21/2004 | EP1272481B1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 04/21/2004 | EP1267900B1 Emulsion containing a triterpen containing plant extract, method for producing said emulsion and for obtaining a plant extract |
| 04/21/2004 | EP1196159B1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 04/21/2004 | EP1039916B8 Use of at least one fucane for the manufacture of a medicament for the treatment of periodontal pathologies |
| 04/21/2004 | EP1007065B1 Preparation of collagen |
| 04/21/2004 | EP0815218B1 Human vegf-specific antisense oligonucleotides |
| 04/21/2004 | CN1491230A Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 04/21/2004 | CN1491227A Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine A3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating |
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1491222A Piperidinee derivatives as neurokinin/antagonists |
| 04/21/2004 | CN1491220A Lactone compound as novel photoinitiators |
| 04/21/2004 | CN1491197A Tropolone derivative |
| 04/21/2004 | CN1491099A Use of [š�-hydroxy-N-methyl-L-leucine9] cyclosporin A for hair growth |
| 04/21/2004 | CN1490036A Chemical for promoting growth of hairs and preventnig sinility |
| 04/21/2004 | CN1490030A Antiradiation health tea for improving immunity |
| 04/21/2004 | CN1490022A Medicine for treating plane warts |
| 04/21/2004 | CN1490019A Health cosmetic composition |
| 04/21/2004 | CN1146665C Method of modulating melanin synthesis |
| 04/21/2004 | CN1146564C Antibiotic sultam and sultone drived oxazolidiones |
| 04/21/2004 | CN1146562C Thtraphydrothiopy 2,3-diazanaphthylaone derivatives as PDE4 inhibitors |
| 04/21/2004 | CN1146545C Benzoylpyridazines |
| 04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
| 04/21/2004 | CN1146441C Composition of containing lympha toxin beta receptor |
| 04/21/2004 | CN1146387C Composition containing L-2-keto thiazolidine-4-carboxylic acid in continuous aqueous phase |
| 04/20/2004 | US6723855 Chlorinating 5-methylisoxazole-4-carboxylic acid by reacting with chlorinating agent to form 5-methylisoxazole-4-carboxylic acid chloride, reacting with 4-trifluoromethylaniline in presence of alkali metal or alkaline earth metal bicarbonate |
| 04/20/2004 | US6723830 Short peptides which selectively modulate the activity of protein kinases |
| 04/20/2004 | US6723755 Method of treating rosacea |
| 04/20/2004 | US6723750 Photodynamic therapy for pre-melanomas |
| 04/20/2004 | US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent |
| 04/20/2004 | US6723744 Indole carboxylic acids as thyroid receptor ligands |
| 04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
| 04/20/2004 | US6723730 Capsaicin receptor ligands |
| 04/20/2004 | US6723726 Protein tyrosine kinase inhibitors |
| 04/20/2004 | US6723704 For cosmetics, drugs, moisturizer |
| 04/20/2004 | US6723694 Short peptides which selectively modulate intracellular signalling |
| 04/20/2004 | US6723525 Methods and compositions for screening modulators of lipid kinases |
| 04/20/2004 | US6723354 Methods and means for preventing or treating inflammation or pruritis |
| 04/20/2004 | US6723350 Powder of one or more antimicrobial metals formed with atomic disorder; coating becomes antimicrobial and anti-inflammatory when wet. |
| 04/20/2004 | US6723344 Useful as implantable devices and wound dressings as the matrix of the invention is designed to be used in conjunction with such devices to provide protracted and controlled release of growth factor, to promote wound healing |
| 04/20/2004 | US6723327 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 04/20/2004 | CA2255229C Use of cinnamic acid, or of its derivatives, as a firming agent in a cosmetic composition |
| 04/15/2004 | WO2004031386A1 Method of examining atopic dermatitis |
| 04/15/2004 | WO2004031177A1 2-aminobenzimidazole derivative |
| 04/15/2004 | WO2004031122A1 Novel curcumin/tetrahydrocurcumin derivatives for using in cosmetics, pharmaceuticals and for nutrition |
| 04/15/2004 | WO2004030691A1 Sustained release preparation containing nk4 |
| 04/15/2004 | WO2004030676A1 External preparation for inhibiting keloid formation |
| 04/15/2004 | WO2004030671A2 Use of 4-amino-quinazolines as anti cancer agents |
| 04/15/2004 | WO2004030645A1 Use of a pear must extract as active principle in a cosmetic and/or pharmaceutical composition |
| 04/15/2004 | WO2004030605A2 Cosmetic formulations based on a gel-forming and/or thickening agent and applications of same |
| 04/15/2004 | WO2004017962A3 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004012650A3 Cosmetic or dermopharmaceutical compositions containing kombucha |
| 04/15/2004 | WO2004006836A3 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
| 04/15/2004 | WO2004005309A3 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/15/2004 | WO2003106381A3 Human adam-10 inhibitors |
| 04/15/2004 | WO2003068141A3 Cosmetic or dermopharmaceutical compositions which are used to reduce bags and circles under the eyes |
| 04/15/2004 | WO2003066064A3 Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics |
| 04/15/2004 | WO2003059951A3 Novel anti-igf-ir antibodies and uses thereof |
| 04/15/2004 | WO2003059297A8 Dermatological topical compositions and a process for the preparation thereof |
| 04/15/2004 | WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 04/15/2004 | WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure |
| 04/15/2004 | WO2003002756A9 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 04/15/2004 | WO2003002722A9 T cell regulatory genes and methods of use thereof |
| 04/15/2004 | WO2002100354B1 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 04/15/2004 | WO2002069980A3 Pharmaceutically effective ginsenosides and their use |
| 04/15/2004 | WO2002062361A8 Antiviral composition containing propolis and essential oils |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | WO2002041885A8 Treatment of inflammation and associated complications using pseudohalides |
| 04/15/2004 | WO2002009690A8 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 04/15/2004 | WO2002000611A9 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/15/2004 | US20040073277 High fluence rate activation of photosensitizers for dermatological applications |
| 04/15/2004 | US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072914 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 04/15/2004 | US20040072913 Skin disorders; induce cell differentiation; using plant extract |
| 04/15/2004 | US20040072890 Anticancer agents |
| 04/15/2004 | US20040072888 Administering pyrazoloanthrone compound |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 04/15/2004 | US20040072876 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 04/15/2004 | US20040072870 Anticancer agents |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072850 Caspase inhibitors and uses thereof |
| 04/15/2004 | US20040072842 Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent |
| 04/15/2004 | US20040072841 Topical administration of oxazolidinones for transdermal delivery |
| 04/15/2004 | US20040072840 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders |
| 04/15/2004 | US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072804 Anticancer agents; skin disorders; bone disorders |